The Diazyme SAA Assay is based on a latex enhanced immunoturbidimetric assay. When an antigen-antibody reaction occurs between SAA in a sample and anti-SAA antibodies which have been sensitized to latex particles, agglutination occurs.
| Product | Catalog Number | Format |
|---|---|---|
| Kit | DZ626A-KY1 | R1: 1 x 60 mL R2: 1 x 15 mL |
| Calibrator | DZ626A-CAL | Cal: 5 x 1 mL |
| Control | DZ626A-CON | Con: 2 x 1 mL |
Product Features
- Fast test results (<10 minutes) for a rapid turnaround time
- Low sample volume required
- Wide range of instrument parameters available for simplifying implementation
- Liquid stable reagent kit; lyophilized calibrator and control sets offered separately
Downloads
Assay Principle
The Diazyme SAA Assay is based on a latex enhanced immunoturbidimetric assay. When an antigen-antibody reaction occurs between SAA in a sample and anti-SAA antibodies which have been sensitized to latex particles, agglutination occurs. This agglutination is detected as an absorbance change (660 nm), with the magnitude of the change being proportional to the quantity of SAA in the sample. The actual concentration is then determined from a 6-point calibration curve prepared from calibrators of known concentrations.
Intended use
The Diazyme SAA Assay is for the quantitative determination of SAA (serum amyloid A) levels in human serum. For research use only in the USA. Not for use in diagnostic procedures. For Research Use Only in U.S.A.
Regulatory Status
